This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Eriko Matsuda
Head of Lead Identification, Discovery Biologics at Chugai Pharmaceutical Co. Ltd.
Speaker

Profile

Eriko Matsuda, a head of lead identification in discovery biologics department in Chugai, has 10+ years of experience in antibody research. She started her career in 2007 and had been in charge of high-throughput screening of small molecules. Since 2012 she has worked on identification and engineering/optimization of antibody and development of antibody technology including TwoB-Ig® technology.

Agenda Sessions

  • Extracellular protein degradation by biparatopic sweeping antibody

    9:15am